Estimating the current and future burden of communicable diseases in the European Union and EEA/EFTA

[1]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[2]  A. Ammon,et al.  The surveillance of communicable diseases in the European Union--a long-term strategy (2008-2013). , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[4]  M. Kretzschmar,et al.  Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries , 2010, PLoS medicine.

[5]  Majid Ezzati,et al.  The burden of disease and injury in the United States 1996 , 2006, Population health metrics.

[6]  L. Johnston,et al.  Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro , 2009, BMC infectious diseases.

[7]  P. Chauvin,et al.  Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. , 2008, Health policy.

[8]  A. Infuso,et al.  Current Situation and Regional Perspective on HIV/AIDS Surveillance in Europe , 2003, Journal of acquired immune deficiency syndromes.

[9]  Kim Moesgaard Iburg,et al.  Summary measures of population health. An overview. , 2002, Danish medical bulletin.

[10]  Ching Choi,et al.  World Health Statistics 2007 [Book Review] , 2008 .

[11]  N. Crowcroft,et al.  Hepatitis A surveillance in England – how many cases are not reported and does it really matter? , 2006, Epidemiology and Infection.

[12]  S. Anand,et al.  Disability-adjusted life years: a critical review. , 1997, Journal of health economics.

[13]  C. Barbot,et al.  Variant Creutzfeldt–Jakob disease: the first confirmed case from Portugal shows early onset, long duration and unusual pathology , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  A. Amato-Gauci,et al.  Tuberculosis in the EU and EEA/EFTA countries: what is the latest data telling us? , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  B S SANDERS,et al.  MEASURING COMMUNITY HEALTH LEVELS. , 1964, American journal of public health and the nation's health.

[16]  Anthony M. A. Smith,et al.  Sex in Australia: Sexually transmissible infection and blood‐borne virus history in a representative sample of adults , 2003, Australian and New Zealand journal of public health.

[17]  R. Romero-Ortuño.  Access to health care for illegal immigrants in the EU: should we be concerned? , 2004 .

[18]  N. Andrews,et al.  European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays. , 2000, Vaccine.

[19]  K. Juel,et al.  The AIDS epidemic in the city of Copenhagen, Denmark: Potential years of life lost and impact on life expectancy , 2005, Scandinavian journal of public health.

[20]  C. Hoebe,et al.  Reinfections, Persistent Infections, and New Infections After General Population Screening for Chlamydia trachomatis Infection in The Netherlands , 2005, Sexually transmitted diseases.

[21]  Victor R. Preedy,et al.  Handbook of disease burdens and quality of life measures , 2010 .

[22]  F. Hamers,et al.  HIV in central and eastern Europe , 2003, The Lancet.

[23]  Gilbert GREUB,et al.  Seroprevalence of Coxiella burnetii and Brucella abortus among pregnant women. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  H. Aggad,et al.  Prevalence of bovine and human brucellosis in western Algeria: comparison of screening tests. , 2006, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[25]  M. Massari,et al.  Comparison of pertussis surveillance systems in Europe. , 2007, Vaccine.

[26]  M. Fallah,et al.  Iran cancer incidence should be corrected for under-ascertainment in cancer cases in the elderly (aged 65+). , 2007, Asian Pacific journal of cancer prevention : APJCP.

[27]  R. Jacobson.  The seroepidemiology of measles in Western Europe. , 2001 .

[28]  H. Hausen,et al.  The search for infectious causes of human cancers: where and why. , 2009, Virology.

[29]  M. Wasay,et al.  The Burden of Stroke in Pakistan , 2008, International journal of stroke : official journal of the International Stroke Society.

[30]  C. Murray,et al.  Understanding DALYs (disability-adjusted life years). , 1997, Journal of health economics.

[31]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Mooi,et al.  Seasonal patterns in time series of pertussis , 2009, Epidemiology and Infection.

[33]  M. Schwenkglenks,et al.  Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons , 2008, BMC public health.

[34]  K. Cartwright.  Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management , 2002, European Journal of Pediatrics.

[35]  Underreporting of Meningococcal Disease Incidence in the Netherlands: Results from a Capture–Recapture Analysis Based on Three Registration Sources with Correction for False Positive Diagnoses , 2006, European Journal of Epidemiology.

[36]  A. Markotić,et al.  A serosurvey reveals Bosnia and Herzegovina as a Europe's hotspot in hantavirus seroprevalence , 2009, Epidemiology and Infection.

[37]  Bryan Grenfell,et al.  Sexually transmitted diseases: Epidemic cycling and immunity , 2005, Nature.

[38]  D. Mellor,et al.  Q Fever in Migrant Workers, Scotland , 2007, Emerging infectious diseases.

[39]  Y. Hsieh,et al.  Underreporting and underestimation of gonorrhea cases in the Taiwan National Gonorrhea Notifiable Disease System in the Tainan region: evaluation by a pilot physician-based sentinel surveillance on Neisseria gonorrhoeae infection. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[40]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[41]  E. Mcnamara,et al.  Laboratory-based surveillance of human verocytotoxigenic Escherichia coli infection in the Republic of Ireland, 2002-2004. , 2005, Journal of medical microbiology.

[42]  Foodborne Bacterial Infection and Hospitalization: A Registry-Based Study , 2006 .

[43]  Jee-Peng Tan,et al.  HANDBOOK ON ECONOMIC ANALYSIS OF INVESTMENT OPERATIONS , 1996 .

[44]  S. Majowicz,et al.  Burden of acute gastrointestinal illness in Canada, 1999-2007: interim summary of NSAGI activities. , 2008, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[45]  J. Hiller,et al.  Climate change and disability-adjusted life years. , 2007, Journal of environmental health.

[46]  Julio Frenk,et al.  Burden of disease assessment and health system reform: Results of a study in Mexico , 1995 .

[47]  D. Caugant,et al.  Seroepidemiological Study after a Long-Distance Industrial Outbreak of Legionnaires' Disease , 2009, Clinical and Vaccine Immunology.

[48]  J. Guégan,et al.  An evaluation of the actual incidence of tuberculosis in French Guiana using a capture-recapture model. , 2006, Microbes and infection.

[49]  M. Panaro,et al.  Intestinal protozoa in HIV-infected patients in Apulia, South Italy , 1999, Epidemiology and Infection.

[50]  D J Nokes,et al.  Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. , 1999, Statistics in medicine.

[51]  I. Fisher.  The Enter-net international surveillance network - how it works. , 1999, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[52]  Joseph E. Aldy,et al.  The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World , 2003 .

[53]  K. Ekdahl,et al.  Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998–2002, assessed by the capture–recapture method , 2005, Epidemiology and Infection.

[54]  T. B. Ustün,et al.  Global "burden of disease"-study for psychiatric disorders. , 2001, Psychiatrische Praxis.

[55]  D. Falzon,et al.  In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[56]  Arie H Havelaar,et al.  Disability Adjusted Life Years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens , 2008, Population health metrics.

[57]  C. Jessica E. Metcalf,et al.  Seasonality and comparative dynamics of six childhood infections in pre-vaccination Copenhagen , 2009, Proceedings of the Royal Society B: Biological Sciences.

[58]  G. Goldman.  Using capture-recapture methods to assess varicella incidence in a community under active surveillance. , 2003, Vaccine.

[59]  Alan D. Lopez,et al.  Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors , 2008, The Medical journal of Australia.

[60]  C. Mcgilchrist,et al.  Loglinear models using capture-recapture methods to estimate the size of a measles epidemic. , 1996, Journal of clinical epidemiology.

[61]  S. Hales,et al.  Climate change and human health: present and future risks , 2006, The Lancet.

[62]  M. Mcclellan.  Are the returns to technological change in health care declining? , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Rainer Muenz,et al.  Aging and demographic change in European societies : main trends and alternative policy options , 2007 .

[64]  W. Edmunds,et al.  The seroepidemiology of rubella in western Europe , 2000, Epidemiology and Infection.

[65]  R. Sutter,et al.  Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. , 1990, American journal of epidemiology.

[66]  E. Laumann,et al.  Population-based study of chlamydial infection in China: a hidden epidemic. , 2003, JAMA.

[67]  A. Reid,et al.  Q fever in Ireland. A seroprevalence study of exposure to Coxiella burnettii among Department of Agriculture workers. , 2004, Occupational medicine.

[68]  I. Chi,et al.  Trends in Disability-Free Life Expectancy Among Chinese Older Adults , 2009, Journal of aging and health.

[69]  Laura C Rodrigues,et al.  Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance , 1999, BMJ.

[70]  H. Zeller,et al.  Serosurvey for West Nile virus in horses in southern France , 2005, Veterinary Record.

[71]  H. D. de Melker,et al.  Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? , 2010, Vaccine.

[72]  D. Sullivan,et al.  Conceptual problems in developing an index of health. , 1966, Vital and health statistics. Series 2, Data evaluation and methods research.

[73]  J. Sterne,et al.  Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study , 2005, BMJ : British Medical Journal.

[74]  A. M'Kendrick.  Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.

[75]  J C Jager,et al.  Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. , 2000, Sexually transmitted diseases.

[76]  D. Coulombier,et al.  Chikungunya risk assessment for Europe: recommendations for action. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[77]  R. Levins,et al.  Impact of deforestation and agricultural development on anopheline ecology and malaria epidemiology. , 2007, The American journal of tropical medicine and hygiene.

[78]  A. Williams,et al.  Calculating the global burden of disease: time for a strategic reappraisal? , 1999, Health economics.

[79]  P. Nunn,et al.  HIV seroprevalence among new TB patients in the civilian and prisoner populations of Donetsk Oblast, Ukraine , 2008, Scandinavian journal of infectious diseases.

[80]  E. Tasheva,et al.  Investigation of the spread of brucellosis among human and animal populations in southeastern Bulgaria, 2007. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[81]  P. van Damme,et al.  Hepatitis B prevention in Europe: a preliminary economic evaluation. , 1995, Vaccine.

[82]  M. Airoldi,et al.  Adjusting life for quality or disability: stylistic difference or substantial dispute? , 2009, Health economics.

[83]  L. Burruano,et al.  HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. , 2009, Gender medicine.

[84]  P. Garvey,et al.  Epidemiology of human cryptosporidiosis in Ireland, 2004-2006: analysis of national notification data. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[85]  C. Mathers.  Cause‐deleted Health Expectancies , 2003 .

[86]  Anthony J McMichael,et al.  Social and environmental risk factors in the emergence of infectious diseases , 2004, Nature Medicine.

[87]  A. Nardone,et al.  The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries , 2008, Epidemiology and Infection.

[88]  F. Gutiérrez,et al.  A bibliometric overview of infectious diseases research in European countries (2002–2007) , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[89]  Debbie Bradshaw,et al.  Initial burden of disease estimates for South Africa, 2000. , 2003, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[90]  Marc Brisson,et al.  Modeling cervical cancer prevention in developed countries. , 2008, Vaccine.

[91]  K. Rüütel,et al.  Modelling Estonia’s concentrated HIV epidemic , 2009 .

[92]  D. Falzon,et al.  What is tuberculosis surveillance in the European Union telling us? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  P. G. Davey,et al.  Health and Economic Impacts of Antibiotic Resistance in European Hospitals – Outlook on the BURDEN Project , 2008, Infection.

[94]  S. Allender,et al.  The burden of alcohol-related ill health in the United Kingdom. , 2009, Journal of public health.

[95]  F. Gleason,et al.  Biology of Microorganisms Thomas D. Brock , 1971 .

[96]  M. Fallah,et al.  Correction for under-ascertainment in cancer cases in the very elderly (aged 75+): external reference method , 2008, Cancer Causes & Control.

[97]  Laurence T. Lam.  Different quantitative measures of the impact of premature deaths on the community in Australia , 2004, Australian and New Zealand journal of public health.

[98]  J. Cuzick,et al.  HPV DNA testing in cervical cancer screening: from evidence to policies. , 2006, Gynecologic oncology.

[99]  T. Szucs,et al.  Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. , 2005, Vaccine.

[100]  F. Merletti,et al.  Undetected burden of tuberculosis in a low-prevalence area. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[101]  K Dietz,et al.  Proportionate mixing models for age-dependent infection transmission , 1985, Journal of mathematical biology.

[102]  J. Patz,et al.  Climate change and health: global to local influences on disease risk , 2006, Annals of tropical medicine and parasitology.

[103]  A. Kraigher,et al.  Outbreak of Q fever among a group of high school students in Slovenia, March-April 2007. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[104]  G. Gmel,et al.  Association of alcohol consumption to mortality and person-years of life lost in Switzerland – Measuring the impact of some methodological options , 2004, European Journal of Epidemiology.

[105]  M. Kretzschmar,et al.  High impact of migration on the prevalence of chronic hepatitis B in the Netherlands , 2008, European journal of gastroenterology & hepatology.

[106]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[107]  R. Vogelmann,et al.  The role of bacterial pathogens in cancer. , 2007, Current opinion in microbiology.

[108]  C. Joseph.  Legionnaires' disease in Europe 2000–2002 , 2004, Epidemiology and Infection.

[109]  D. De Angelis,et al.  An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales , 2009, Statistical methods in medical research.

[110]  A. Aguzzi,et al.  Incidence of Creutzfeldt-Jakob disease in Switzerland , 2002, The Lancet.

[111]  S B Thacker,et al.  Public health surveillance in the United States. , 1988, Epidemiologic reviews.

[112]  George W. Torrance,et al.  Social preferences for health states: An empirical evaluation of three measurement techniques , 1976 .

[113]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[114]  A. Siitonen,et al.  Campylobacter-triggered reactive arthritis: a population-based study. , 2002, Rheumatology.

[115]  A M Downs,et al.  Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe , 1997, AIDS.

[116]  Z. Memish,et al.  Epidemiology of Antituberculosis Drug Resistance in Saudi Arabia: Findings of the First National Survey , 2013, Antimicrobial Agents and Chemotherapy.

[117]  J. Ironside,et al.  Validation of diagnostic criteria for variant Creutzfeldt–Jakob disease , 2010, Annals of Neurology.

[118]  A H Havelaar,et al.  The burden of infectious diseases in Europe: a pilot study. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[119]  P. Ostrosky-Wegman,et al.  Role of infectious diseases in human carcinogenesis , 2005, Environmental and molecular mutagenesis.

[120]  Wilhelm Kirch,et al.  Encyclopedia of public health , 2008 .

[121]  M. Owings,et al.  Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. , 2005, Archives of internal medicine.

[122]  A. Clarke,et al.  An evaluation of completeness of tuberculosis notification in the United Kingdom , 2003, BMC public health.

[123]  Alan D. Lopez,et al.  Quantifying disability: data, methods and results. , 1994, Bulletin of the World Health Organization.

[124]  A. Galvani,et al.  Disability adjusted life years lost to dengue in Brazil , 2009, Tropical medicine & international health : TM & IH.

[125]  A. Nardone,et al.  The European Sero‐Epidemiology Network 2: standardization of assay results for hepatitis B virus , 2007, Journal of viral hepatitis.

[126]  M. Brisson,et al.  Deaths from pertussis are underestimated in England , 2002, Archives of disease in childhood.

[127]  M. Rabodonirina,et al.  Prevalence of intestinal protozoans in French patients infected with HIV. , 1993, Journal of acquired immune deficiency syndromes.

[128]  J. Schellekens,et al.  Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis , 2002, Epidemiology and Infection.

[129]  Jonathan A. Patz,et al.  Unhealthy Landscapes: Policy Recommendations on Land Use Change and Infectious Disease Emergence , 2004, Environmental health perspectives.

[130]  M. McBean,et al.  Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. , 2001, The Journal of infectious diseases.

[131]  R. V. van Lingen,et al.  Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98. , 2002, Paediatric and perinatal epidemiology.

[132]  W. Mcnab,et al.  Magnitude and distribution of acute, self-reported gastrointestinal illness in a Canadian community , 2004, Epidemiology and Infection.

[133]  Wendy Macdowall,et al.  Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours , 2001, The Lancet.

[134]  Peter Gerner-Smidt,et al.  Submitting articles to the BMJ , 2003, BMJ : British Medical Journal.

[135]  J. Bryant,et al.  Health policy approaches to measuring and valuing human life: conceptual and ethical issues. , 1995, American journal of public health.

[136]  L. Kapiriri,et al.  Can the value choices in DALYs influence global priority-setting? , 2004, Health policy.

[137]  H. Adami,et al.  Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.

[138]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[139]  M. Boily,et al.  Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries , 2009, Public Health Genomics.

[140]  J. Verhoef,et al.  Bacterial resistance: A sensitive issue , 2006, Drug Resistance Updates.

[141]  F. Segura,et al.  Short report: seroprevalence of human infection by Coxiella burnetii in Barcelona (northeast of Spain). , 2006, The American journal of tropical medicine and hygiene.

[142]  A. Omran.  The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.

[143]  S. Mariotti,et al.  Years of life lost due to premature mortality in Italy , 2002, European Journal of Epidemiology.

[144]  Chris Drakeley,et al.  Serology: a robust indicator of malaria transmission intensity? , 2007, Trends in parasitology.

[145]  R. Hayes,et al.  Sexual behaviour and HIV/sexually transmitted infection risk behaviours in the general population of Slovenia, a low HIV prevalence country in central Europe , 2008, Sexually Transmitted Infections.

[146]  M. Pocchiari.  Prevalence of variant CJD in the UK , 2009, BMJ : British Medical Journal.

[147]  S. Franceschi,et al.  Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. , 2008, European journal of cancer.

[148]  Song Liang,et al.  Environmental Determinants of Infectious Disease: A Framework for Tracking Causal Links and Guiding Public Health Research , 1997, Environmental health perspectives.

[149]  H. Tiemeier,et al.  Mortality and disability: the effect of overweight and obesity , 2009, International Journal of Obesity.

[150]  S. D. de Vlas,et al.  Under-reporting of HIV infection among cohorts of TB patients in the WHO European Region, 2003-2004. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[151]  Sue J Goldie,et al.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. , 2008, PharmacoEconomics.

[152]  P. Fayers.  Outcomes Assessment in Cancer: Measures, Methods, and Applications , 2006, Quality of Life Research.

[153]  Mirjam Kretzschmar,et al.  Costs and Effects of Chlamydial Screening: Dynamic versus Static Modeling , 2005, Sexually transmitted diseases.

[154]  S. Henson,et al.  Estimation of the costs of acute gastrointestinal illness in British Columbia, Canada. , 2008, International journal of food microbiology.

[155]  R. Romi,et al.  Infection with chikungunya virus in Italy: an outbreak in a temperate region , 2007, The Lancet.

[156]  U. Siebert,et al.  HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality , 2009, BMC public health.

[157]  Mark Jit,et al.  Economic evaluation of human papillomavirus vaccination in the United Kingdom , 2008, BMJ : British Medical Journal.

[158]  Y. Tselentis,et al.  Active surveillance of Q fever in human and animal population of Cyprus , 2006, BMC infectious diseases.

[159]  M. Weinstein,et al.  QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[160]  D. Fryback,et al.  HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. , 2002, Annual review of public health.

[161]  J. Lünemann,et al.  Antiviral immune responses: triggers of or triggered by autoimmunity? , 2009, Nature Reviews Immunology.

[162]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[163]  Mirjam Kretzschmar,et al.  The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. , 2006, The Journal of infection.

[164]  Kate E. Jones,et al.  Global trends in emerging infectious diseases , 2008, Nature.

[165]  M. P. van der Linden,et al.  Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. , 2009, Vaccine.

[166]  Alan D. Lopez,et al.  Comparative quantification of health risks: Conceptual framework and methodological issues , 2003, Population health metrics.

[167]  Piero Manfredi,et al.  Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example. , 2004, Mathematical biosciences.

[168]  Robert Schlaberg,et al.  XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors , 2009, Proceedings of the National Academy of Sciences.

[169]  H. V. van Kranen,et al.  Estimated number of new cancer cases attributable to infection in the Netherlands in 2003. , 2008, Cancer letters.

[170]  A. Krämer,et al.  Calculation of health expectancies with administrative data for North Rhine-Westphalia, a Federal State of Germany, 1999–2005 , 2009, Population health metrics.

[171]  A. Nicoll,et al.  Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. , 2001, The Pediatric infectious disease journal.

[172]  J. Barendregt.  Incidence- and prevalence-based SMPH: making the twain meet , 2002 .

[173]  J. Desenclos,et al.  [Evaluation of the exhaustiveness and representativeness of a surveillance system using the capture-recapture method. Application to the surveillance of meningococcal infections in France in 1989 and 1990]. , 1993, Revue d'epidemiologie et de sante publique.

[174]  A. Aguzzi,et al.  Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada , 2005, Neurology.

[175]  H. Sørensen,et al.  Socioeconomic factors and risk of hospitalization with infectious diseases in 0- to 2-year-old Danish children , 2005, European Journal of Epidemiology.

[176]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[177]  Kara Hanson,et al.  DALYs: efficiency versus equity , 1998 .

[178]  H. Rieder,et al.  [Tuberculosis control in Europe and international migration]. , 1994, Revue d'epidemiologie et de sante publique.

[179]  M. Nauta,et al.  Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157 , 2004, Epidemiology and Infection.

[180]  J. Stockman,et al.  Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis , 2010 .

[181]  D. Schenzle.  An age-structured model of pre- and post-vaccination measles transmission. , 1984, IMA journal of mathematics applied in medicine and biology.

[182]  C. Murray,et al.  A critical examination of summary measures of population health. , 2000, Bulletin of the World Health Organization.

[183]  Maria Zambon,et al.  Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. , 2005, The Journal of infectious diseases.

[184]  T. Vos,et al.  The burden of disease in Zimbabwe in 1997 as measured by disability‐adjusted life years lost , 2006, Tropical medicine & international health : TM & IH.

[185]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .

[186]  D. Wagener,et al.  Summary measures of population health: addressing the first goal of healthy people 2010, improving health expectancy. , 2001, Healthy People 2010 statistical notes : from the Centers for Disease Control and Prevention/National Center for Health Statistics.

[187]  R. Reintjes,et al.  Assessing the sensitivity of STD surveillance in the Netherlands: an application of the capture–recapture method , 1999, Epidemiology and Infection.

[188]  D. Persing,et al.  Infection, immunity, and cancer. , 1999, Archives of pathology & laboratory medicine.

[189]  H. Caswell.  Matrix population models : construction, analysis, and interpretation , 2001 .

[190]  C. Murray,et al.  Global burden of disease , 1997, The Lancet.

[191]  R. Naulin,et al.  Analysis of a model of bovine brucellosis using singular perturbations , 1994, Journal of mathematical biology.

[192]  I. Brown,et al.  Seroprevalence of H1N1, H3N2 and H1N2 influenza viruses in pigs in seven European countries in 2002–2003 , 2008, Influenza and other respiratory viruses.

[193]  L. McCaig,et al.  Food-related illness and death in the United States. , 1999, Emerging infectious diseases.

[194]  I. Angelillo,et al.  A seroepidemiologic survey on Brucellosis antibodies in southern Italy , 1997, Infection.

[195]  R. Reinert.  Pneumococcal conjugate vaccines--a European perspective. , 2004, International journal of medical microbiology : IJMM.

[196]  Hude Quan,et al.  BMC Health Services Research BioMed Central Correspondence , 2006 .

[197]  K. Mølbak,et al.  High prevalence of antibodies to Legionella spp. in Danish blood donors. A study in areas with high and average incidence of Legionnaires' disease , 2007, Epidemiology and Infection.

[198]  A. Amato-Gauci,et al.  Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system? , 2010, Vaccine.

[199]  A. Tarantola,et al.  Imported cases of chikungunya in metropolitan France: update to June 2006. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[200]  C. Castillo-Chavez,et al.  Using mark-recapture methodology to estimate the size of a population at risk for sexually transmitted diseases. , 1992, Statistics in medicine.

[201]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[202]  Niels Keiding,et al.  Statistical inference in the Lexis diagram , 1990, Philosophical Transactions of the Royal Society of London. Series A: Physical and Engineering Sciences.

[203]  T. Trussell,et al.  Applied Mathematical Demography. , 1978 .

[204]  G. Carrin,et al.  Human health benefits from livestock vaccination for brucellosis: case study. , 2003, Bulletin of the World Health Organization.

[205]  M. Salminen,et al.  Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. , 2004, AIDS research and human retroviruses.

[206]  Executive Summary,et al.  AnnuAl EPidEmiologiCAl REPoRT on CommuniCABlE diSEASES in EuRoPE 2008 REPoRT on THE STATuS of CommuniCABlE diSEASES in THE Eu And EEA / EfTA CounTRiES , 2007 .

[207]  Alan D. Lopez,et al.  Progress and directions in refining the global burden of disease approach: a response to Williams. , 2000, Health economics.

[208]  C. Murray,et al.  Age weights and discounting in health gaps reconsidered , 2003 .

[209]  J. Kaldor,et al.  Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. , 2009, Brain : a journal of neurology.

[210]  Elamin H Elbasha,et al.  Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. , 2006, Epidemiologic reviews.

[211]  E. Nord,et al.  The value of DALY life: problems with ethics and validity of disability adjusted life years , 1999, BMJ.

[212]  D. Campbell-Lendrum,et al.  Comparative Risk Assessment of the Burden of Disease from Climate Change , 2006, Environmental health perspectives.

[213]  Y. V. van Duynhoven,et al.  Gastroenteritis in sentinel general practices,The Netherlands. , 2001, Emerging infectious diseases.

[214]  A. Efstratiou,et al.  Eighth International Meeting of the European Laboratory Working Group on Diphtheria and the Diphtheria Surveillance Network--June 2004: progress is needed to sustain control of diphtheria in European Region. , 2004, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[215]  Donald T. Rowland,et al.  Demographic Methods and Concepts , 2003 .

[216]  R. Mikolajczyk,et al.  Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.

[217]  M. Temmerman,et al.  Antenatal HIV screening in Europe: a review of policies. , 2007, European journal of public health.

[218]  R. Black,et al.  International Public Health : Diseases, Programs, Systems, and Policies , 2000 .

[219]  Y. Lim,et al.  Assessing the burden of disease and injury in Los Angeles County using disability-adjusted life years. , 2002, Public health reports.

[220]  P. Strebel,et al.  Reporting efficiency during a measles outbreak in New York City, 1991. , 1993, American journal of public health.

[221]  T. Sobotka.  Is lowest-low fertility in Europe explained by the postponement of childbearing? , 2004 .

[222]  R. Holman,et al.  Rocky mountain spotted fever hospitalizations among American Indians. , 2006, The American journal of tropical medicine and hygiene.

[223]  C. Murray.  Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators , 2007, The Lancet.

[224]  V. Vullo,et al.  Reemergence of Human and Animal Brucellosis, Bulgaria , 2009, Emerging infectious diseases.

[225]  G. Cassell.  Infectious causes of chronic inflammatory diseases and cancer. , 1998, Emerging infectious diseases.

[226]  J. Hadler,et al.  Burden of self-reported acute diarrheal illness in FoodNet surveillance areas, 1998-1999. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[227]  N. Mueller.  Overview: viral agents and cancer. , 1995, Environmental health perspectives.

[228]  D. Raoult,et al.  Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[229]  H. D. de Melker,et al.  Ascertainment of meningococcal disease in Europe. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[230]  D. Sullivan,et al.  A single index of mortality and morbidity. , 1971, HSMHA health reports.

[231]  J. Ironside,et al.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey , 2009, BMJ : British Medical Journal.

[232]  B. Steinhoff,et al.  Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. , 2007, Brain : a journal of neurology.

[233]  B. Fritzell,et al.  Burden of paediatric invasive pneumococcal disease in Europe, 2005 , 2006, Epidemiology and Infection.

[234]  R. Netherlands,et al.  The Bleak Future of Antibiotics , 2022 .

[235]  J. Harte,et al.  Missing feedbacks, asymmetric uncertainties, and the underestimation of future warming , 2006 .

[236]  P. Manfredi,et al.  Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. , 2004, International journal of epidemiology.

[237]  Stephen Begg,et al.  Burden of disease and injury , , 2022 .

[238]  F. Mahoney,et al.  Hospital-based surveillance for acute febrile illness in Egypt: a focus on community-acquired bloodstream infections. , 2005, The American journal of tropical medicine and hygiene.

[239]  E. Fèvre,et al.  Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. , 2002, Bulletin of the World Health Organization.

[240]  J. Marinković,et al.  Burden of ischaemic heart disease and cerebrovascular diseases in Serbia without Kosovo and Metohia, 2000 , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[241]  W. Fierz,et al.  Cross-sectional survey on hantavirus seroprevalence in Canton St. Gallen, Switzerland. , 2007, Swiss medical weekly.

[242]  M. Carton,et al.  Under-reporting of notifiable infectious disease hospitalizations in a health board region in Ireland: room for improvement? , 2007, Epidemiology and Infection.

[243]  P. Bonanni,et al.  Measurement and reporting of burden of disease for hepatitis A: results of the EUROHEP.NET feasibility survey. , 2007, European journal of public health.

[244]  S. A. Abdool Karim,et al.  Reasons for under-reporting of notifiable conditions. , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[245]  M. Cortina-Borja,et al.  Rubella seroprevalence in pregnant women in North Thames: estimates based on newborn screening samples , 2009, Journal of medical screening.

[246]  S. Huhulescu,et al.  Etiology of Acute Gastroenteritis in Three Sentinel General Practices, Austria 2007 , 2009, Infection.

[247]  R. Sutter,et al.  Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. , 1992, JAMA.

[248]  J. Mossong,et al.  Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg , 2006, Epidemiology and Infection.

[249]  A E Ades,et al.  Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. , 2008, Biostatistics.

[250]  T. Leitner,et al.  Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups. , 2004, AIDS research and human retroviruses.

[251]  R. Scragg,et al.  Under-notification of giardiasis in Auckland, New Zealand: a capture–recapture estimation , 2004, Epidemiology and Infection.

[252]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[253]  G. Craun,et al.  Serological responses to Cryptosporidium-specific antigens in Czech populations with different water sources , 2007, Epidemiology and Infection.

[254]  Joshua A. Salomon,et al.  National burden of disease Studies: a practical guide. Global Program on Evidence for Health Policy , 2001 .

[255]  Y. V. van Duynhoven,et al.  Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. , 2001, American journal of epidemiology.

[256]  P. Beutels,et al.  Reviewing the Cost Effectiveness of Rotavirus Vaccination , 2012, PharmacoEconomics.

[257]  H. Dodhia,et al.  Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years. , 2008, Journal of public health.

[258]  H. Sørensen,et al.  Maternal prenatal lifestyle factors and infectious disease in early childhood: a follow-up study of hospitalization within a Danish birth cohort. , 2001, Pediatrics.

[259]  Ronald N. Jones,et al.  Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). , 2004, Diagnostic microbiology and infectious disease.

[260]  S. Allender,et al.  The burden of overweight and obesity‐related ill health in the UK , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[261]  F. Sassi.  Calculating QALYs, comparing QALY and DALY calculations. , 2006, Health policy and planning.

[262]  J. Takkinen,et al.  European survey on Campylobacter surveillance and diagnosis 2001. , 2003, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[263]  I. Bakken,et al.  Chlamydia trachomatis Among Young Norwegian Men: Sexual Behavior and Genitourinary Symptoms , 2007, Sexually transmitted diseases.

[264]  L. Gallagher.  Hepatitis B. , 2016, Journal.

[265]  Y. V. van Duynhoven,et al.  Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[266]  K. Sachse,et al.  A serological study on brucellosis in wild boars in Germany , 2007, European Journal of Wildlife Research.

[267]  R. Pebody,et al.  Estimating tuberculosis case mortality in England and Wales, 2001-2002. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[268]  Jan J Barendregt,et al.  A generic model for the assessment of disease epidemiology: the computational basis of DisMod II , 2003, Population health metrics.

[269]  R. Pebody,et al.  The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella , 2000, Epidemiology and Infection.

[270]  J. Kaldor,et al.  Hepatitis C prevalence--a nationwide serosurvey. , 2004, Communicable diseases intelligence quarterly report.

[271]  P. Martínez-Martín,et al.  Surgery and Risk of Sporadic Creutzfeldt-Jakob Disease in Denmark and Sweden: Registry-Based Case-Control Studies , 2008, Neuroepidemiology.

[272]  A. Nardone,et al.  The seroepidemiology of Bordetella pertussis infection in Western Europe , 2004, Epidemiology and Infection.

[273]  N. Andrews,et al.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.

[274]  Julie Ratcliffe,et al.  Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[275]  H. Goossens,et al.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. , 2009, The Journal of antimicrobial chemotherapy.

[276]  E. L. Miller,et al.  The sero-epidemiology of diphtheria in Western Europe , 2000, Epidemiology and Infection.

[277]  A. Nardone,et al.  Model selection methodology for inter-laboratory standardisation of antibody titres. , 2005, Vaccine.

[278]  A. Siitonen,et al.  Shigatoxigenic Escherichia coli (STEC) infections in Finland during 1998–2002: a population-based surveillance study , 2005, Epidemiology and Infection.

[279]  R. Pebody,et al.  Pneumococcal disease surveillance in Europe. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[280]  C. Bertelli,et al.  Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men , 2008, BMC infectious diseases.